Evidence map›Paper›PMID 39804931›Full record

ArticlePLoS pathogens2025

Genomic exploration of the journey of Plasmodium vivax in Latin America.

Margaux J M Lefebvre, Fanny Degrugillier, Céline Arnathau, Gustavo A Fontecha, Oscar Noya, Sandrine Houzé, Carlo Severini, Bruno Pradines, Antoine Berry, Jean-François Trape and 4 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Genomic Insights Into Host Shifts BetweenEvolutionary applications · 2026
    Article
  5. Molecular Characterization ofTropical medicine and infectious disease · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Margaux J M LefebvreMiVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France.ORCID 0000-0002-9339-8657
Fanny DegrugillierMiVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France.
Céline ArnathauMiVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France.
Gustavo A FontechaInstituto de Investigaciones en Microbiología, Facultad de Ciencias, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Oscar NoyaInfectious Diseases Section, "Dr. Felix Pifano" Tropical Medicine Institute, Central University of Venezuela, Caracas, Venezuela.
Sandrine HouzéUniversité de Paris, MERIT, IRD, Paris, France.
Carlo SeveriniDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Bruno PradinesUnité parasitologie et entomologie, Institut de Médecine Tropicale du Service de Santé des Armées, Marseille, France.
Antoine BerryInstitut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), Université de Toulouse, CNRS UMR5051, INSERM UMR 1291, UPS, Toulouse, France.
Jean-François TrapeMiVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France.
Fabian E SáenzCentro de Investigación para la Salud en América Latina, Facultad de Ciencias Exactas y Naturales, Pontificia Universidad Católica del Ecuador, Quito, Ecuador.
Franck PrugnolleREHABS, International Research Laboratory, CNRS-NMU-UCBL, George Campus, Nelson Mandela University, George, South Africa.
Michael C FontaineMiVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France.
Virginie RougeronREHABS, International Research Laboratory, CNRS-NMU-UCBL, George Campus, Nelson Mandela University, George, South Africa.

Funding

French Institute for Public Health SurveillanceFrench National Research AgencyPontificia Universidad Católica del Ecuador
6 · The paper itself

Abstract

Plasmodium vivax is the predominant malaria parasite in Latin America. Its colonization history in the region is rich and complex, and is still highly debated, especially about its origin(s). Our study employed cutting-edge population genomic techniques to analyze whole genome variation from 620 P. vivax isolates, including 107 newly sequenced samples from West Africa, Middle East, and Latin America. This sampling represents nearly all potential source populations worldwide currently available. Analyses of the genetic structure, diversity, ancestry, coalescent-based inferences, including demographic scenario testing using Approximate Bayesian Computation, have revealed a more complex evolutionary history than previously envisioned. Indeed, our analyses suggest that the current American P. vivax populations predominantly stemmed from a now-extinct European lineage, with the potential contribution also from unsampled populations, most likely of West African origin. We also found evidence that P. vivax arrived in Latin America in multiple waves, initially during early European contact and later through post-colonial human migration waves in the late 19th-century. This study provides a fresh perspective on P. vivax's intricate evolutionary journey and brings insights into the possible contribution of West African P. vivax populations to the colonization history of Latin America.

Indexed as

Genome, ProtozoanMalaria, VivaxPlasmodium vivaxGenetic VariationGenomicsHumansLatin AmericaPhylogeny

Identifiers

PMID39804931
PMCPMC11761655

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.